KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 151 filers reported holding KITE PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $40,720,000 | +573.3% | 226,458 | +288.1% | 0.02% | +533.3% |
| Q2 2017 | $6,048,000 | +157.8% | 58,344 | +95.3% | 0.00% | +200.0% |
| Q1 2017 | $2,346,000 | -65.9% | 29,880 | -80.5% | 0.00% | -75.0% |
| Q4 2016 | $6,870,000 | +39.0% | 153,199 | +73.2% | 0.00% | +33.3% |
| Q3 2016 | $4,941,000 | -23.5% | 88,462 | -31.5% | 0.00% | -25.0% |
| Q2 2016 | $6,458,000 | +240.6% | 129,171 | +212.8% | 0.00% | +300.0% |
| Q1 2016 | $1,896,000 | -83.7% | 41,300 | -78.1% | 0.00% | -87.5% |
| Q4 2015 | $11,630,000 | +86.5% | 188,732 | +68.5% | 0.01% | +100.0% |
| Q3 2015 | $6,236,000 | +42.1% | 111,998 | +55.6% | 0.00% | +33.3% |
| Q2 2015 | $4,389,000 | +12.5% | 71,996 | +6.4% | 0.00% | 0.0% |
| Q1 2015 | $3,902,000 | +280.3% | 67,654 | +280.2% | 0.00% | +200.0% |
| Q4 2014 | $1,026,000 | – | 17,793 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|